Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
The current price of Eli Lilly And Co in the market is 1 059,3 €, with a 24-hour trading volume of 2,39B €. The asset's market cap is 944,62B €, after moving -0.01% in the last day.
Tokenized Eli Lilly And Co is trading at 1 061,16 €, with a tokenized market cap of 41,13M € and a 24-hour trading volume of 1,95M €. The tokenized asset has moved 0.83% in the past 24 hours.